Medical device market access in Ecuador is regulated by the National Agency for Regulation, Control and Health Surveillance (ARCSA). All medical devices intended for sale, import, or distribution in Ecuador must obtain either a Sanitary Registration Certificate (Registro Sanitario) or complete the applicable Sanitary Registration Notification (Notificación al Registro Sanitario) procedure before being placed on the market.
Medical Device Classification
Ecuador classifies medical devices into four risk-based categories:
- Class I – Low Risk
- Class II – Low-to-Moderate Risk
- Class III – Moderate-to-High Risk
- Class IV – High Risk
Classification is determined based on factors such as device invasiveness, duration of use, active implantability, and interaction with the human body or energy sources.
Registration Pathway
The standard registration process for imported medical devices includes the following requirements:
- Applications must be submitted through ARCSA’s VUE (Ventanilla Única Ecuatoriana) online platform.
- Overseas manufacturers must appoint a legally established Local Authorized Representative (LAR) in Ecuador.
- Registration dossiers must be submitted in Spanish, although certain technical documents may be accepted in English.
- Devices already approved by recognized reference regulatory authorities, such as the U.S. FDA, EU CE, or Japan’s MHLW, may be eligible for a simplified registration pathway, subject to ARCSA’s requirements.
Core Documentation Requirements
The following documents are generally required for all device classes:
- Completed VUE application form.
- Power of Attorney (Carta Poder) between the manufacturer and the Ecuadorian Authorized Representative.
- Certificate of Free Sale (CFS/CLV) or an equivalent document.
- Quality Management System certificate (e.g., ISO 13485 or GMP, where applicable).
- Spanish-language product labels and Instructions for Use (IFU).
- Technical documentation, including product description, components, design drawings, and manufacturing flowcharts.
- Stability study data (where applicable).
- Sterility validation or certification (where applicable).
- Biocompatibility data (where applicable).
- Clinical evidence or meta-analysis for high-risk medical devices.
Additional Requirements by Risk Classification
| Risk Class | Additional Requirements |
|---|---|
| Class I | Basic technical documentation; clinical evidence is generally not required. |
| Class II | Technical specifications and detailed product component information. |
| Class III | Biocompatibility studies and selected clinical evidence. |
| Class IV | Comprehensive clinical evaluation, sterility and stability data, and software validation (where applicable). |
Note: Class III and Class IV medical devices are generally not eligible for the simplified registration pathway.
Registration Procedure and Timelines
The registration process typically consists of the following steps:
- Submission of the application and supporting documents through the VUE system.
- Administrative and technical review conducted by ARCSA.
- If deficiencies are identified, applicants are generally granted one opportunity to respond within five working days.
- Upon approval, ARCSA issues the registration decision and records the product in its regulatory database.
Typical Review Timelines
- Simplified Procedure: Approximately 15 working days
- Standard Procedure: Approximately 30–60 working days
Registration Validity and Renewal
- Registration certificates are generally valid for at least five years.
- Renewal applications should be submitted no later than 90 days before expiration, together with updated technical documentation and labeling information.
Change Management and Registration Notification Mechanism
Ecuador has established a Registration Notification mechanism that allows certain administrative changes without requiring a full registration amendment, provided that the changes do not affect the device’s safety, quality, effectiveness, or intended use.
Eligible notification categories include:
| Notification Code | Change Description |
| NDM01 | HS tariff code update |
| NDM02 | Correction of registration certificate information |
| NDM03 | Change of Technical Responsible Person |
| NDM04 | Change of Legal Representative |
| NDM05 | Change of Marketing Authorization Holder’s address (excluding manufacturing site) |
| NDM06 | Formatting updates to labels or IFU |
| NDM07 | Applicant address update |
| NDM08 | Batch numbering system update |
| NDM11 | Change of OEM/private label manufacturer or packaging facility (ISO/GMP documentation required) |
Applicants should ensure that these changes do not alter the device’s intended purpose, safety profile, or performance characteristics.
Key Compliance Considerations
Manufacturers and importers should pay particular attention to the following regulatory requirements:
- Product labels and Instructions for Use must be provided in Spanish.
- All application documents must be uploaded to the VUE platform in PDF format.
- Technical documentation must include the electronic signature of the designated Technical Responsible Person.
- Devices labeled “Single Use Only” must not be reprocessed or reused.
- Medical devices must not be split or repackaged for separate commercial distribution.
- Electronic Certificates of Free Sale (CFS/CLV) are accepted, provided their authenticity can be verified through the issuing authority.
Manufacturers planning to enter the Ecuadorian market should ensure that registration dossiers are fully compliant with ARCSA requirements before submission. Proper preparation of technical documentation, labeling, and local representation can significantly improve registration efficiency and facilitate successful market access.